Clifford E. Berkman

Professor

Washington State University
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (6)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

New targeted chemotherapeutics are urgently needed to minimize off-target toxicity and reduce the high-mortality rate associated with metastatic prostate cancer. Herein, we report on the modular synthesis, pharmacokinetics, and efficacy of two small-molecule–drug conjugates (SMDC) targeted to prostate-specific membrane antigen (PSMA) incorporating either: (i) a cathepsin-B–cleavable valine–citrulline (Val–Cit), or (ii) an acid-cleavable phosphoramidate linker. Crucial components used in the design of the conjugates include: (i) CTT1298, a nanomolar affinity ligand that binds irreversibly to PSMA and has proven in past studies to rapidly internalize and shuttle payloads into PSMA-expressing prostate cancer cells, (ii) MMAE, a known potent cytotoxic payload, and (iii) an albumin-binder, proven to improve residence time of drug conjugates. At dose of 0.8 mg/kg (∼250 nmol/kg), the two SMDCs showed significant efficacy in a PSMA(+) PC3-PIP mouse model of human prostate cancer compared with controls, without inducing systemic toxicity. Though localization of the SMDCs was observed in tissues apart from the tumor, release of MMAE was observed predominantly in tumor tissue, at levels that were 2–3 orders of magnitude higher than non-target tissues. Furthermore, SMDC2, which incorporated a novel pH-responsive phosporamidate linker, demonstrated significantly improved efficacy over SMDC1 that has a Val–Cit linker, with a 100% survival over 90 days and 4 out of 8 mice showing complete tumor growth inhibition after 6 weekly doses of 0.8 mg/kg (244 nmol/kg). Our findings demonstrate the potential of irreversible PSMA inhibitors combined with pH-responsive linkers as a way to specifically deliver chemotherapeutic drugs to prostate cancer tumors with minimal toxicity.

Year:

2022

Collaborators (27)

Steven G. Boxer

Professor

Stanford University

UNITED STATES
View details

Yu-Shan Lin

Professor of Chemistry and Dean of Academic Affairs for Arts and Sciences

Tufts University

UNITED STATES
View details

Ronald Castellano

Professor

University of Florida

UNITED STATES
View details

William T. Pennington

Department Chair

Clemson University

UNITED STATES
View details

Ricardo Metz

Professor

University of Massachusetts Amherst

UNITED STATES
View details

D. Howard Fairbrother

-

UNITED STATES
View details

Linda Columbus

Professor

University of Virginia

UNITED STATES
View details

Anjali Sharma

Assistant Professor

Washington State University

UNITED STATES
View details

Tristan H. Lambert

Cornell University

UNITED STATES
View details

Wei Kong

Oregon State University

UNITED STATES
View details

Gregory J. Szulczewski

-

UNITED STATES
View details

Vicki H. Wysocki

Professor, School chair

Georgia Institute of Technology

UNITED STATES
View details

Laura J. Kaufman

Columbia University

UNITED STATES
View details

Gregory S. Ferguson

Professor and Chair

Lehigh University

UNITED STATES
View details

Frieder Jäkle

Distinguished Professor

Rutgers University

UNITED STATES
View details

Michael Burkart

Professor

University of California, San Diego

UNITED STATES
View details

Jin Zhang

Distinguished Professor

-

UNITED STATES
View details

Karen Allen

Professor

Boston University

UNITED STATES
View details

Melody Fulton

Staff Scientist

Washington State University

UNITED STATES
View details

Victoria J. DeRose

University of Oregon

UNITED STATES
View details

P. B. Armentrout

Distinguished Professor

University of Utah

UNITED STATES
View details

Matthew P. Shores

Colorado State University

UNITED STATES
View details

Lai-Sheng Wang

Brown University

UNITED STATES
View details

Christy Haynes

University of Minnesota

UNITED STATES
View details

Catherine J. Murphy

Larry R. Faulkner Endowed Chair in Chemistry

University of Illinois at Urbana-Champaign

UNITED STATES
View details

Kenneth Knappenberger

Professor

The Pennsylvania State University - University Park Campus

UNITED STATES
View details

Alexander M. Spokoyny

University of California

UNITED STATES
View details